The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

The FDA wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies ...

Drugmakers are urging the Trump administration and EU officials to exclude medical goods from expanding tariffs wars ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in ... Mounjaro from competitor Eli Lilly had also ended. “We are pleased the FDA has declared that supply of the ...

Wegovy is a brand-name subcutaneous injection prescribed for weight loss and reduction of cardiovascular risks. Its cost with and without insurance can depend on several factors, such as whether ...

The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...

If you want to take Wegovy, a glucagon-like peptide-1 (GLP-1) receptor agonist, here are some things to keep in mind about getting it online. We also provide some accredited and trusted online ...

Wegovy (semaglutide) is a brand-name subcutaneous injection (shot) prescribed for weight loss and to lower the risk of cardiovascular problems in some people. As with other drugs, Wegovy can cause ...